Organization
Pfizer Inc, Inflammation and Immunology, Collegeville, PA, United States of America
1 abstract
Abstract
ANALYSIS OF DISEASE ACTIVITY MEASURES IN THE CONTEXT OF A METHOTREXATE WITHDRAWAL STUDY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB 11 MG ONCE DAILY + METHOTREXATE: POST HOC ANALYSIS OF DATA FROM ORAL SHIFTOrg: Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Department of Medicine, Dallas, TX, United States of America, Institut de Rhumatologie de Montréal, Montreal, QC, Canada, School of Biological Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, Pfizer Inc, Inflammation and Immunology, Montreal, QC, Canada,